Ligand validation:5CVH

IHP: INOSITOL HEXAKISPHOSPHATE

IHP is a Ligand Of Interest in 5CVH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CVH_IHP_A_402	65%	25%	0.099	0.901	1.19	1.85	3	14	0	0	100%	0.5
5CVH_IHP_B_402	34%	35%	0.12	0.801	0.89	1.64	-	9	0	0	100%	0.5
3W8L_IHP_B_501	42%	55%	0.147	0.867	0.78	0.96	-	-	0	0	100%	1
5MPJ_IHP_A_402	12%	56%	0.247	0.775	0.75	0.94	-	-	1	0	100%	0.5
5MOE_IHP_A_404	10%	54%	0.221	0.729	0.73	1.04	-	1	0	0	100%	0.5
5OQU_IHP_A_408	10%	50%	0.241	0.742	1.13	0.82	3	1	0	0	100%	0.5
5ORJ_IHP_A_407	6%	33%	0.355	0.792	1.06	1.6	-	8	0	0	100%	1
1ZY7_IHP_A_901	99%	47%	0.055	0.989	1.01	1.03	2	3	0	0	100%	1
9D5J_IHP_A_801	99%	52%	0.047	0.976	0.97	0.89	3	1	4	0	100%	1
8YJC_IHP_A_3802	98%	45%	0.063	0.986	1.36	0.8	5	1	0	0	100%	1
3HO6_IHP_A_270	97%	24%	0.072	0.985	2.14	1	15	3	0	0	100%	1
9D5K_IHP_A_801	96%	41%	0.055	0.962	0.77	1.51	1	11	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.